Columbus Hill Capital Management’s Novartis NVS Stock Holding History

Columbus Hill Capital Management’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-52,258	Closed	-$4.02M	–	61
2017 Q3	$4.02M	Sell	52,258 -15,418	-23%	-$1.16M	0.29%	51
2017 Q2	$5.06M	Sell	67,676 -2,074	-3%	-$147K	0.51%	41
2017 Q1	$4.64M	Buy	+69,750	New	+$4.65M	0.23%	49

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Columbus Hill Capital Management's NVS Position: Q4 2017 in Review

Columbus Hill Capital Management sold out of Novartis (NVS) in Q4 2017, closing a stake of 52,258 shares — an estimated $4.02M sold.

Columbus Hill Capital Management first reported a position in NVS in Q1 2017 and held it in 3 quarters. The position peaked at $5.06M in Q2 2017. 1,006 funds tracked by Wall St. Rank hold NVS as of Q4 2017.

Columbus Hill Capital Management reported no remaining Novartis position as of Q4 2017 after selling out during the quarter.
Columbus Hill Capital Management sold 52,258 Novartis shares in Q4 2017, an estimated $4.02M.
Columbus Hill Capital Management first reported a position in Novartis in Q1 2017 and held it in 3 quarters.
Columbus Hill Capital Management's Novartis position peaked at $5.06M in Q2 2017.
1,006 funds tracked by Wall St. Rank held Novartis as of Q4 2017.

Based on Columbus Hill Capital Management's 13F filing for Q4 2017, filed 13 Feb 2018.